ImportRefusal LogoImportRefusal

Boehringer Ingelheim Hellas A.E.

⚠️ Moderate Risk

FEI: 3013350267 • Koropi, Attiki • GREECE

FEI

FEI Number

3013350267

📍

Location

Koropi, Attiki

🇬🇷

Country

GREECE
🏢

Address

5th Km Paiania-Markopoulo, , Koropi, Attiki, Greece

Moderate Risk

FDA Import Risk Assessment

44.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
5
Unique Violations
9/3/2025
Latest Refusal
5/24/2017
Earliest Refusal

Score Breakdown

Violation Severity
58.0×40%
Refusal Volume
17.7×30%
Recency
78.5×20%
Frequency
2.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
9/3/2025
61PCY73EMPAGLIFLOZIN (ANTI-DIABETIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/24/2017
62UDA99ANTI-TUSSIVE/COLD N.E.C.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
472NO ENGLISH
Division of Northeast Imports (DNEI)

Frequently Asked Questions

What is Boehringer Ingelheim Hellas A.E.'s FDA import refusal history?

Boehringer Ingelheim Hellas A.E. (FEI: 3013350267) has 2 FDA import refusal record(s) in our database, spanning from 5/24/2017 to 9/3/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Boehringer Ingelheim Hellas A.E.'s FEI number is 3013350267.

What types of violations has Boehringer Ingelheim Hellas A.E. received?

Boehringer Ingelheim Hellas A.E. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Boehringer Ingelheim Hellas A.E. come from?

All FDA import refusal data for Boehringer Ingelheim Hellas A.E. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.